Drugs Made In America Acquisition Corp. Rights (DMAAR) Stock Price
DMAARStock
$0.12
Market Cap$2.55M
P/E44.30x
PEG Ratio—
Div yield—
Beta-0.02
DMAAR Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-13.96%
Price vs S&P 500 (4W)0.58%
VGM Score53.19
P/E Ratio (Annual)44.30x
Industry Peers — Blank Checks / SPACs(955)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Indicated Dividend Yield (Annual) | ROE (TTM) | P/B Ratio (Quarterly) | Price |
|---|---|---|---|---|---|---|---|---|
DMAARDrugs Made In America Acquisition Corp. Rights | — | D | B | 44.3x | — | 2.9% | 1.9x | $0.12 |
| DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares | — | — | C | 77.3x | — | 2.7% | 1.3x | $10.18 |
| EVACEQV Ventures Acquisition Corp. II | — | — | B | 54.3x | — | — | 1.0x | $10.31 |
| BCSSBain Capital GSS Investment Corp. | — | — | C | 141.4x | — | — | 1.3x | $10.29 |
| CXIIChurchill Capital Corp XII Class A Ordinary Shares | — | — | B | — | — | — | 1.5x | $10.79 |
| CEPFCantor Equity Partners IV, Inc. Class A Ordinary Shares | — | — | C | 96.0x | — | 3.1% | 1.3x | $10.30 |
| DBCAD. Boral Acquisition I Corp. Class A Ordinary Shares | — | — | C | — | — | — | — | $10.03 |
| AEXAAmerican Exceptionalism Acquisition Corp. A | — | — | D | — | — | -0.4% | 1.7x | $11.14 |
| GCGRGeneral Catalyst Global Resilience Merger Corp. Class A Ordinary Shares | — | — | D | — | — | — | — | $10.12 |
| NWAXNew America Acquisition I Corp. | — | — | D | 1050.0x | — | — | — | $10.08 |
| AACAres Acquisition Corporation III | — | — | C | 36.3x | — | -0.8% | 1.8x | $10.12 |